A new market analysis indicates exponential growth in the global oral proteins and peptides market, projecting an expansion from USD 6,350.0 million in 2023 to USD 26,936.2 million by 2031, exhibiting a remarkable CAGR of 20.13% during the forecast period of 2024-2031. The market value is estimated to be USD 7,462.0 million in 2024. This significant growth is primarily attributed to the continuous advancements in oral drug delivery technologies for proteins and peptides, coupled with the increasing patient preference for convenient oral formulations over injectable ones.
Read Complete Report Details: https://www.kingsresearch.com/oral-proteins-and-peptides-market-1481
The comprehensive report analyzes the global oral proteins and peptides market, segmenting it by drug type (linaclotide, plecanatide, calcitonin, others), by application (diabetes, gastrointestinal disorders, bone diseases, hormonal disorders, others), and regional landscape. This detailed segmentation provides valuable insights into the market's dynamics and emerging trends.
Key drivers fueling the market's expansion include:
- Advancements in Oral Drug Delivery Technologies: Innovations in formulation and delivery systems are overcoming the challenges associated with oral administration of proteins and peptides, such as enzymatic degradation and poor permeability.
- Increasing Patient Preference for Oral Formulations: Oral drugs offer greater convenience, ease of administration, and improved patient compliance compared to injectable therapies.
- Growing Prevalence of Target Diseases: The rising incidence of chronic diseases such as diabetes, gastrointestinal disorders, and bone diseases is increasing the demand for effective oral protein and peptide therapeutics.
- Expanding Research and Development Activities: Pharmaceutical companies are heavily investing in research and development to expand the pipeline of orally available protein and peptide drugs.
- Potential for Improved Market Access and Patient Reach: Oral formulations can potentially improve market access and reach a wider patient population compared to injectable drugs that often require administration by healthcare professionals.
The report also highlights key market trends:
- Development of Novel Enzyme Inhibitors and Permeation Enhancers: Research is focused on developing more effective enzyme inhibitors and permeation enhancers to protect proteins and peptides in the gastrointestinal tract and enhance their absorption.
- Use of Nanoparticle-Based Delivery Systems: Nanoparticle-based drug delivery systems are being explored to improve the stability and bioavailability of oral proteins and peptides.
- Focus on Targeted Drug Delivery: Strategies for targeted delivery of oral proteins and peptides to specific sites in the body are being investigated to enhance efficacy and reduce side effects.
- Increasing Collaborations and Partnerships: Pharmaceutical companies are increasingly collaborating with technology providers to leverage their expertise in oral drug delivery.
- Regulatory Support for Innovative Oral Formulations: Positive regulatory developments for novel oral protein and peptide formulations are encouraging further innovation in this field.
This report offers a strategic overview of the global oral proteins and peptides market, providing valuable insights for pharmaceutical companies, drug delivery technology providers, research institutions, and investors seeking to capitalize on the growing potential of this innovative drug delivery route.
About Kings Research
Kings Research is a leading market research and consulting firm that provides comprehensive market intelligence and strategic insights to businesses across various industries.
Explore More Reports:
Japan’s Near-Infrared Technology Transforms Calorie Tracking
